Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

48.88

-0.56 (-1.13%)

At close: Mar 28, 2025, 4:00 PM

49.04

+0.16 (0.33%)

After-hours: Mar 28, 2025, 7:50 PM EDT

Protagonist Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	434.43	60	26.58	27.36	28.63	Upgrade
Revenue Growth (YoY)	624.05%	125.72%	-2.84%	-4.44%	12293.07%	Upgrade
Gross Profit	434.43	60	26.58	27.36	28.63	Upgrade
Selling, General & Admin	43.46	33.49	31.74	27.2	18.64	Upgrade
Research & Development	138.13	120.16	126.22	126.01	74.51	Upgrade
Operating Expenses	181.59	153.65	157.95	153.2	93.14	Upgrade
Operating Income	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
Interest Expense	-	-	-	-	-0.6	Upgrade
Interest & Investment Income	26.32	14.9	4.06	0.44	0.9	Upgrade
Currency Exchange Gain (Loss)	0.25	-0.2	-0.08	-0.15	-0.05	Upgrade
EBT Excluding Unusual Items	279.41	-78.96	-127.39	-125.55	-64.26	Upgrade
Other Unusual Items	-	-	-	-	-0.59	Upgrade
Pretax Income	279.41	-78.96	-127.39	-125.55	-64.85	Upgrade
Income Tax Expense	4.22	-	-	-	1.31	Upgrade
Net Income	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Net Income to Common	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Shares Outstanding (Basic)	62	57	49	46	34	Upgrade
Shares Outstanding (Diluted)	65	57	49	46	34	Upgrade
Shares Change (YoY)	14.65%	15.74%	5.87%	34.67%	32.84%	Upgrade
EPS (Basic)	4.47	-1.39	-2.60	-2.71	-1.92	Upgrade
EPS (Diluted)	4.23	-1.39	-2.60	-2.71	-1.92	Upgrade
Free Cash Flow	182.8	-70.85	-108.93	-108.97	-72.96	Upgrade
Free Cash Flow Per Share	2.81	-1.25	-2.22	-2.35	-2.12	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	58.20%	-156.09%	-494.24%	-460.01%	-225.36%	Upgrade
Profit Margin	63.34%	-131.59%	-479.26%	-458.94%	-231.07%	Upgrade
Free Cash Flow Margin	42.08%	-118.08%	-409.81%	-398.31%	-254.84%	Upgrade
EBITDA	253.67	-92.68	-130.34	-125.03	-63.57	Upgrade
EBITDA Margin	58.39%	-154.46%	-	-	-222.05%	Upgrade
D&A For EBITDA	0.83	0.98	1.03	0.81	0.95	Upgrade
EBIT	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
EBIT Margin	58.20%	-156.09%	-	-	-225.36%	Upgrade
Effective Tax Rate	1.51%	-	-	-	-	Upgrade

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q